David H. Kreling - Publications

Affiliations: 
University of Wisconsin, Madison, Madison, WI 
Area:
Pharmacy, Health Care Management, Public Administration

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Arora P, Look KA, Kreling DH. Does evidence matter? Comparative effectiveness research and prescribing of Type 2 diabetes mellitus drugs. Journal of Comparative Effectiveness Research. PMID 31789054 DOI: 10.2217/Cer-2019-0127  0.4
2016 Mohamed O, Kreling DH. The Impact of a Pricing Policy Change on Retail Prices of Medicines in Egypt. Value in Health Regional Issues. 10: 14-18. PMID 27881272 DOI: 10.1016/J.Vhri.2016.04.004  0.699
2014 Faerber AE, Kreling DH. Content analysis of false and misleading claims in television advertising for prescription and nonprescription drugs. Journal of General Internal Medicine. 29: 110-8. PMID 24030427 DOI: 10.1007/S11606-013-2604-0  0.714
2014 Chen YC, Kreling DH. The effect of the Medicare Part D benzodiazepine exclusion on the utilization patterns of benzodiazepines and substitute medications. Research in Social & Administrative Pharmacy : Rsap. 10: 438-47. PMID 23880428 DOI: 10.1016/J.Sapharm.2013.06.008  0.358
2014 Mohamed O, Kreling D. The Impact Of Direct Price Control On Pharmaceutical Prices In Egypt Value in Health. 17. DOI: 10.1016/J.Jval.2014.03.123  0.695
2013 Kelton CM, Chang LV, Kreling DH. State Medicaid programs missed $220 million in uncaptured savings as generic fluoxetine came to market, 2001-05. Health Affairs (Project Hope). 32: 1204-11. PMID 23836735 DOI: 10.1377/Hlthaff.2013.0161  0.417
2012 Chen YC, Tarn YH, Kreling DH. Public views of community pharmacists in Taiwan. The International Journal of Pharmacy Practice. 20: 203-6. PMID 22554164 DOI: 10.1111/J.2042-7174.2011.00174.X  0.301
2012 Look KA, Mott DA, Leedham RK, Kreling DH, Hermansen-Kobulnicky CJ. Pharmacy participation and claim characteristics in the Wisconsin Medicaid Pharmaceutical Care Program from 1996 to 2007. Journal of Managed Care Pharmacy : Jmcp. 18: 116-28. PMID 22380471 DOI: 10.18553/Jmcp.2012.18.2.116  0.31
2012 Doucette WR, Nevins JC, Gaither C, Kreling DH, Mott DA, Pedersen CA, Schommer JC. Organizational factors influencing pharmacy practice change. Research in Social & Administrative Pharmacy : Rsap. 8: 274-84. PMID 21958467 DOI: 10.1016/J.Sapharm.2011.07.002  0.32
2012 Faerber AE, Kreling DH. Now you see it. Now you don't: fair balance and adequate provision in advertisements for drugs before and after the switch from prescription to over-the-counter. Health Communication. 27: 66-74. PMID 21745037 DOI: 10.1080/10410236.2011.569001  0.707
2012 Faerber AE, Kreling DH. Content Analysis of Television Advertising for Drugs That Switch From Prescription to Over-the-Counter: Balancing Information and Appeals Drug Information Journal. 46: 226-234. DOI: 10.1177/0092861512438765  0.718
2011 Look KA, Mott DA, Kreling DH, Peterson EJ, Staresinic AG. Economic impact of pharmacist-reimbursed drug therapy modification. Journal of the American Pharmacists Association : Japha. 51: 58-64. PMID 21247827 DOI: 10.1331/Japha.2011.09115  0.395
2010 Mott DA, Thorpe JM, Thorpe CT, Kreling DH, Gadkari AS. Effects of Medicare Part D on drug affordability and use: Are seniors with prior high out-of-pocket drug spending affected more? Research in Social & Administrative Pharmacy : Rsap. 6: 90-9. PMID 20511108 DOI: 10.1016/J.Sapharm.2010.02.004  0.372
2009 Gadkari AS, Mott DA, Kreling DH, Bonnarens JK. Pharmacy characteristics associated with the provision of drug therapy services in nonmetropolitan community pharmacies. The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association. 25: 290-5. PMID 19566615 DOI: 10.1111/J.1748-0361.2009.00232.X  0.33
2008 Gadkari AS, Mott DA, Kreling DH, Bonnarens JK. Characteristics of unmet demand for pharmacists: a survey of rural community pharmacies in Wisconsin. Journal of the American Pharmacists Association : Japha. 48: 598-609. PMID 18826899 DOI: 10.1331/Japha.2008.07039  0.333
2003 Craig BM, Kreling DH, Mott DA. Do seniors get the medicines prescribed for them? Evidence from the 1996-1999 Medicare Current Beneficiary Survey. Health Affairs (Project Hope). 22: 175-82. PMID 12757282 DOI: 10.1377/Hlthaff.22.3.175  0.387
2000 Ganther JM, Kreling DH. Consumer perceptions of risk and required cost savings for generic prescription drugs. Journal of the American Pharmaceutical Association (Washington,D.C. : 1996). 40: 378-83. PMID 10853539 DOI: 10.1016/S1086-5802(16)31086-5  0.418
1999 Ganther JM, Kreling DH. Effect of a change in third party reimbursement rate on prescription gross margin. Journal of the American Pharmaceutical Association (Washington,D.C. : 1996). 39: 346-52. PMID 10363461 DOI: 10.1016/S1086-5802(16)30448-X  0.33
1998 Mott DA, Kreling DH. An internal rate of return approach to investigate pharmacist supply in the United States. Health Economics. 3: 373-84. PMID 9435920 DOI: 10.1002/Hec.4730030605  0.304
1998 Mott DA, Schommer JC, Doucette WR, Kreling DH. Agency Theory, Drug Formularies, and Drug Product Selection: Implications for Public Policy Journal of Public Policy & Marketing. 17: 287-295. DOI: 10.1177/074391569801700211  0.381
1993 Kreling DH, Mott DA. The Cost Effectiveness of Drug Utilisation Review in an Outpatient Setting Pharmacoeconomics. 4: 414-436. PMID 10146909 DOI: 10.2165/00019053-199304060-00004  0.363
1992 Kreling DH, Mucha RE. Drug product management in health maintenance organizations American Journal of Health-System Pharmacy. 49: 374-381. DOI: 10.1093/Ajhp/49.2.374  0.445
1991 Kreling DH, Mott DA. Potential economic impact of changes in Medicaid drug program purchasing American Journal of Health-System Pharmacy. 48: 678-680. DOI: 10.1093/Ajhp/48.4.678  0.361
1989 Kreling DH, Knocke DJ, Hammel RW. Changes in market shares for internal analgesic products after a Medicaid formulary restriction. Journal of Pharmaceutical Marketing & Management. 3: 65-76. PMID 10314666 DOI: 10.3109/J058V03N02_06  0.452
1989 Kreling DH, Knocke DJ, Hammel RW. The effects of an internal analgesic formulary restriction on Medicaid drug expenditures in Wisconsin. Medical Care. 27: 34-44. PMID 2562996 DOI: 10.1097/00005650-198901000-00004  0.387
1987 Kreling DH, Wiederholt JB. Selecting health insurance: the importance of prescription drug coverage and pharmacy factors in consumer decision making. Journal of Pharmaceutical Marketing & Management. 1: 3-18. PMID 10283522 DOI: 10.3109/J058V01N04_02  0.343
1987 Kreling D. Pharmacists' Use of Average Wholesale Price in Pricing Prescriptions Journal of Pharmaceutical Marketing & Management. 2: 97-113. DOI: 10.1300/J058V02N01_07  0.406
1986 Kreling DH, Kirk KW. Estimating pharmacy level prescription drug acquisition costs for third-party reimbursement. Medical Care. 24: 590-600. PMID 3523065 DOI: 10.1097/00005650-198607000-00003  0.353
1986 Lipowski EE, Wiederholt JB, Kreling DH, Collins TM. Use of a Medicaid database to analyze pharmaceutical services in long-term-care facilities American Journal of Health-System Pharmacy. 43: 1467-1472. DOI: 10.1093/Ajhp/43.6.1467  0.337
Show low-probability matches.